Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07780136Phase 4Not yet recruiting
A Phase 4 trial of botulinum toxin type A in chronic migraine, sponsored by Assiut University. Planned start Oct 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07780136.